“Patients With Anti-Small Ubiquitin-Like Modifier Activating Enzyme-Positive Dermatomyositis Resembling Antisynthetase Syndrome With Poor Prognosis: A Bicentric International Retrospective Study and Literature Review”. Reumatismo 77, no. 1 (October 9, 2024). Accessed June 26, 2025. https://www.reumatismo.org/reuma/article/view/1686.